As shown in Table 4, recurrent CRC patients had a higher CD3+/CD8+ TILs ratio in invasive margin, whereas no statistical difference was seen for densities of CD3+ or CD8+ TILs in different regions. The gene discussed is CD8A; the disease is colorectal carcinoma.